Capital Markets Deals Review

H1 2021

read timeRead time: 20 mins
In the return to normality, we are proud to have helped so many listed businesses achieve their vision – from listing on Aquis, AIM and the Main Market, to supporting takeovers and acquisitions.  

We are delighted to now see a far broader range of activity in a wider range of sectors, with companies looking to grasp opportunities quickly as the economy reopens. Main Market IPOs included Kanabo Group Plc, MGC Pharmaceuticals Limited and Cellular Goods Plc in February. MGC, leading the way for medicinal cannabis companies on the LSE, raised £6.5m. MGC was shortly followed by Kanobo Group’s reverse takeover in the cannabis space, raising £6m before expenses. We were delighted to act as reporting accountant for all three aforementioned cannabis transactions, which brought the total number of cannabis companies on LSE and AIM to six.

You can read all about the transactions and the companies we supported in our Capital Markets Deals Review H1 2021.

As one of the leading advisors to listed businesses in the UK, according to the respected Corporate Adviser Rankings Guide – the 6th largest auditor to LSE listed companies and 4th ranked for those on AIM – we are here to support your ambitions.